Organigram (OGI) Q1 2025 Earnings Call Transcript
At this time, I would like to welcome everyone to the Organigram Holdings first-quarter fiscal 2025 earnings conference call. After the speaker's remarks, there will be a question-and-answer session.
Vertex Pharmaceuticals (VRTX) Q4 2024 Earnings Call Transcript
Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.C79yHELW.js
Danaos Corporation (DAC) Q4 2024 Earnings Call Transcript
Danaos Corporation ( NYSE: DAC) Q4 2024 Earnings Conference Call February 11, 2025 9:00 AM ET Evangelos Chatzis - Chief Financial Officer John Coustas - Chief Executive Officer
Sonos (SONO) Q1 2025 Earnings Call Transcript
SONO earnings call for the period ending December 31, 2024. Sonos ( SONO 5.19%) Q1 2025 Earnings Call Feb 06, 2025, 4:15 p.m. ET
Proto Labs (PRLB) Q4 2024 Earnings Call Transcript
Proto Labs (NYSE: PRLB) Q4 2024 Earnings Call Feb 07, 2025, 8:30 a.m. ET
BP p.l.c. (BP) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Conference Call February 11, 2025 8:00 AM ETCompany ParticipantsCraig Marshall - Investor RelationsMurray Auchincloss
SiTime (SITM) Q4 2024 Earnings Call Transcript
Good afternoon, and welcome to SiTime's fourth quarter 2024 financial results conference call. At this time, all participants are in a listen-only mode. At the conclusion of today's conference call, instructions will be given for the question-and-answer session. As a reminder, this conference call is being recorded February 5, 2025.
Vertex Pharmaceuticals (VRTX) Sees Strong 2025 Revenue Growth
Biotechnology company Vertex Pharmaceuticals (VRTX) reported mixed results for the fourth quarter of 2024. While revenue surpassed analyst
Arrowhead Pharmaceuticals, Inc. (ARWR) Q1 2025 Earnings Call Transcript
Arrowhead expects to receive a $500 million upfront payment in the next 10 days and has already received $325 million through the purchase by Sarepta of Arrowhead common stock priced at $27.25 per share.
Vertex Pharmaceuticals (VRTX) Misses Q4 Earnings Estimates
Vertex Pharmaceuticals (VRTX) came out with quarterly earnings of $3.98 per share, missing the Zacks Consensus Estimate of $3.99 per share. This compares to earnings of $4.20 per share a year ago. These figures are adjusted for non-recurring items.
Earnings call transcript: Sunoco reports strong Q4 2024 growth
Sunoco LP (SUN), currently valued at $7.54 billion by market cap, recently reported robust financial results for the fourth ...
Insider Monkey on MSN4d
IBEX Limited (NASDAQ:IBEX) Q2 2025 Earnings Call Transcript
Operator: Welcome to the IBEX Second Quarter FY 2025 earnings conference call. At this time, all participants, please be ...
How AI Could Transform the Way You Listen to Earnings Calls
This AI-driven approach goes beyond traditional voice analysis methods by detecting nuanced vocal characteristics ...
Earnings call transcript: Orion Energy's Q3 FY2025 revenue declines, stock dips
Orion Energy Systems (NASDAQ: OESX) reported its third-quarter fiscal year 2025 earnings, revealing a revenue decline to ...
IRSA Inversiones y Representaciones Sociedad Anónima (NYSE:IRS) Q2 2025 Earnings Call Transcript
Q2 2025 Earnings Call Transcript February 7, 2025 Santiago Donato: Good morning, everyone. I’m Santiago Donato, Investor ...
As an Investor, Do You Really Have To Listen to Quarterly Earnings Calls?
Earnings calls provide key pieces of corporate information that can affect stock prices, and today there are shortcuts to save you the tedium.